‹ ›

This content requires a premium subscription.
Please log in or subscribe to continue.
Artwork for Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomized, double-blind, placebo-controlled, phase 2 trial
Evidence Based Medicine presented by InpharmD™

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomized, double-blind, placebo-controlled, phase 2 trial
30
00:00:00 / 00:06:58